Latest news
Loading news…
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Septerna was acquired by Vertex Pharmaceuticals in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
46
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Francisco, California, United States
Key People at Septerna
Chief Legal Officer
Co-Founder and Chief Executive Officer
President
Co-Founder
Co-Founder
Co-Founder
46
professional contacts at Septerna
Contact execs at Septerna →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Septerna
Loading news…
FAQs about Septerna
People who checked this page also checked these
Browse the full Acquirezy directory.